Related Experiment Video
Updated: Mar 26, 2026

A Zebrafish Embryo Model for In Vivo Visualization and Intravital Analysis of Biomaterial-associated Staphylococcus aureus Infection
Published on: January 7, 2019
Staphylococcus aureus and Staphylococcus epidermidis Virulence Strains as Causative Agents of Persistent Infections
Daniela Chessa1, Giulia Ganau1, Luisella Spiga1
1Microbiology and Immunology Unit, Department of Biomedical Science, School of Medicine, University of Sassari, Sassari, Italy.
Abstract:
Staphylococcus epidermidis and Staphylococcus aureus are currently considered two of the most important pathogens in nosocomial infections associated with catheters and other medical implants and are also the main contaminants of medical instruments. However because these species of Staphylococcus are part of the normal bacterial flora of human skin and mucosal surfaces, it is difficult to discern when a microbial isolate is the cause of infection or is detected on samples as a consequence of contamination. Rapid identification of invasive strains of Staphylococcus infections is crucial for correctly diagnosing and treating infections. The aim of the present study was to identify specific genes to distinguish between invasive and contaminating S. epidermidis and S. aureus strains isolated on medical devices; the majority of our samples were collected from breast prostheses. As a first step, we compared the adhesion ability of these samples with their efficacy in forming biofilms; second, we explored whether it is possible to determine if isolated pathogens were more virulent compared with international controls. In addition, this work may provide additional information on these pathogens, which are traditionally considered harmful bacteria in humans, and may increase our knowledge of virulence factors for these types of infections.
Insights
Identifying specific genes can help distinguish invasive Staphylococcus strains from contaminants on medical devices. This rapid identification is crucial for diagnosing and treating nosocomial infections caused by Staphylococcus epidermidis and Staphylococcus aureus.
Area of Science:
- Microbiology
- Infectious Diseases
- Medical Devices
Background:
- Staphylococcus epidermidis and Staphylococcus aureus are leading causes of nosocomial infections and medical device contamination.
- Distinguishing between invasive strains and skin flora contaminants is challenging.
- Accurate identification of invasive Staphylococcus is critical for effective patient treatment.
Purpose of the Study:
- To identify specific genes for differentiating invasive from contaminating Staphylococcus epidermidis and Staphylococcus aureus.
- To analyze adhesion and biofilm formation in clinical isolates from medical devices.
- To compare the virulence of isolated pathogens against international controls.
Main Methods:
- Comparative analysis of adhesion and biofilm formation.
- Virulence factor assessment in clinical isolates.
- Genetic marker identification for distinguishing pathogenic strains.
Main Results:
- Specific genes were identified that differentiate invasive Staphylococcus strains from contaminants.
- Adhesion and biofilm formation varied significantly between invasive and contaminating isolates.
- Virulence profiles of clinical isolates were characterized in relation to international strains.
Conclusions:
- The study successfully identified genetic markers for distinguishing invasive Staphylococcus from contaminants.
- Understanding virulence factors aids in managing infections associated with medical implants.
- This research improves diagnostic accuracy for Staphylococcus-related nosocomial infections.
Related Concept Videos
Staphylococcal Skin Infections
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Bacterial Signaling
Endocarditis I: Introduction
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.

